Related references
Note: Only part of the references are listed.In Vitro and In Vivo Evaluation of Proniosomes Containing Celecoxib for Oral Administration
Mohamed Nasr
AAPS PHARMSCITECH (2010)
The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development
James M. Butler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Advantages of celecoxib nanosuspension formulation and transformation into tablets
Andrej Dolenc et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu
William Curatolo et al.
PHARMACEUTICAL RESEARCH (2009)
A Model-Based Methodology for Spray-Drying Process Development
Dan E. Dobry et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2009)
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Christopher J. H. Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products
Bernard Van Eerdenbrugh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Dwayne T. Friesen et al.
MOLECULAR PHARMACEUTICS (2008)
Pharmaceutical particle engineering via spray drying
Reinhard Vehring
PHARMACEUTICAL RESEARCH (2008)
Oral lipid-based formulations
David J. Hauss
ADVANCED DRUG DELIVERY REVIEWS (2007)
Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappa B-mediated increase of intracellular doxorubicin accumulation
Jens van Wijngaarden et al.
EUROPEAN JOURNAL OF CANCER (2007)
Freeze-drying of nanoparticles: Formulation, process and storage considerations
Wassim Abdelwahed et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
RN Gursoy et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles
RH Muller et al.
JOURNAL OF BIOTECHNOLOGY (2004)
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human
Y Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Characterization of solid-state forms of celecoxib
G Chawla et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Amorphous pharmaceutical solids: preparation, characterization and stabilization
L Yu
ADVANCED DRUG DELIVERY REVIEWS (2001)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Improving drug solubility for oral delivery using solid dispersions
C Leuner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
What is the true solubility advantage for amorphous pharmaceuticals?
BC Hancock et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
